Join us at TIAFT 2016

10 August 2016
Join us at TIAFT 2016

Randox Toxicology are attending the 54th TIAFT meeting in Brisbane, Australia, from 28th August – 1st September 2016. Our representatives are looking forward to welcoming you to Booth 6 & 7. Visit our booth to explore our entire drug screening portfolio and hear about our latest advances in toxicology screening including; Evidence MultiSTAT, Evidence Evolution and our new DoA ULTRA panel.

Evidence MultiSTAT

This year we have a team on hand to carry out demonstrations on the hour every hour on the Evidence MultiSTAT; our latest benchtop biochip analyser. The MultiSTAT simultaneously detects 20 drugs of abuse on-site across oral fluid, urine or blood and generates results in just 17 minutes. Ideal for workplace, custodial and laboratory drug testing- a simple interface and a prefilled reagent cartridges allow anyone to operate the analyser in any environment.

Evidence Evolution

Process any test at any time with our highly versatile Evidence Evolution analyser, including batch analysis, STAT samples or true random access. Achieve fast and accurate laboratory operations with uncompromised quality using our latest high throughput analyser.

DoA ULTRA

Following our customer feedback, we developed DoA ULTRA, the most comprehensive drug screen yet. DoA ULTRA is the ultimate drugs of abuse array which detects up to 20 targeted drugs, offering the largest cross-reactivity profile of over 240 analytes.


Poster Presentations

Our Research & Development Scientists, Dr Richard Acheson and Victoria Anderson, will be presenting our posters at TIAFT. Visit P1/P2 on the Plaza Level to learn about our latest research. 


Poster Session 1:

Board number: P054
Evaluation of a biochip-based immunoassay for the rapid screening of 6-monoacetylmorphine in human oral fluid by using the Evidence MultiSTAT

Poster Session 2:
Board number: P201
Development of a new ELISA for the screening of oxycodone in blood and urine

Board number: P170
Development of the first ELISA for the screening of alpha-PVP, alpha-PVP related compounds and metabolites in blood and urine

Board number: P178
Development of a new ELISA for the detection of pregabalin in human biological samples


We look forward to seeing you in Brisbane!

To arrange a meeting or book a demonstration time, please contact info@randoxtoxicology.com


UK: +44 (0)28 9442 2413
USA: +1 304 728 2890